VeriMomIst cordyceps sinensis mycelium extract in der Schwangerschaft sicher?
No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment identifying reproductive or developmental toxicity for Cordyceps sinensis mycelium extract. Peer‑reviewed literature on Cordyceps reports bioactive constituents (e.g., cordycepin) with various pharmacologic effects, but no consistent animal or human reproductive/developmental toxicity data were identified to indicate a reproductive hazard. Dermal exposure from cosmetics may give low but measurable systemic exposure to small molecules in extracts (hence e=1). Sources consulted: ECHA Annex VI (no entry), PubMed, PubChem, CosIng, EWG.
Related ingredients
Frequently asked questions
- Ist cordyceps sinensis mycelium extract in der Schwangerschaft sicher?
- No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment identifying reproductive or developmental toxicity for Cordyceps sinensis mycelium extract. Peer‑reviewed literature on Cordyceps reports bioactive constituents (e.g., cordycepin) with various pharmacologic effects, but no consistent animal or human reproductive/developmental toxicity data were identified to indicate a reproductive hazard. Dermal exposure from cosmetics may give low but measurable systemic exposure to small molecules in extracts (hence e=1). Sources consulted: ECHA Annex VI (no entry), PubMed, PubChem, CosIng, EWG.
- Ist cordyceps sinensis mycelium extract während des Stillens sicher?
- No evidence from regulatory listings or authoritative safety assessments (CIR/SCCS/ECHA Annex VI) of transfer into breastmilk or lactation-specific toxicity. Mechanistic data indicating placental or milk transfer are lacking; therefore no mechanistic concern is assigned. Low but measurable systemic absorption is possible from topical use, so exposure to nursing mother is considered low (e=1). Sources: PubMed, PubChem, CosIng, ECHA Annex VI, EWG.
- Ist cordyceps sinensis mycelium extract sicher für Babyhaut?
- No infant-specific reproductive or developmental toxicity data were identified and no regulatory flags for developmental toxicity exist. Mechanistic concerns for infant skin are not identified. Because infant skin has higher surface‑area‑to‑weight and a less mature barrier, exposure score is increased by +1 relative to adult (adult e=1 → baby e=2) to reflect higher potential per‑kg uptake from topical application of extracts containing small molecules. Sources: PubMed, PubChem, CosIng, ECHA Annex VI, EWG.
- Wie bewertet VeriMom cordyceps sinensis mycelium extract?
- VeriMom bewertet cordyceps sinensis mycelium extract mit 93/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu cordyceps sinensis mycelium extract?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu cordyceps sinensis mycelium extract basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.